Cargando…

Digital ischaemia aetiologies and mid-term follow-up: A cohort study of 323 patients

Upper extremity digital ischaemia (UEDI) is a rare heterogeneous condition whose frequency is 40 times less than that of toe ischaemia. Using a large cohort, the aim of this study was to evaluate aetiologies, prognosis and midterm clinical outcomes of UEDI. All patients with UEDI with or without cut...

Descripción completa

Detalles Bibliográficos
Autores principales: Raimbeau, Alizée, Pistorius, Marc-Antoine, Goueffic, Yann, Connault, Jérôme, Plissonneau-Duquene, Pierre, Maurel, Blandine, Reignier, Jean, Asehnoune, Karim, Artifoni, Mathieu, Didier, Quentin, Gautier, Giovanni, Trochu, Jean-Nöel, Rozec, Bertrand, N’Gohou, Chan, Durant, Cécile, Pottier, Pierre, Denis Le Sève, Julien, Brebion, Nicolas, Agard, Christian, Espitia, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136985/
https://www.ncbi.nlm.nih.gov/pubmed/34011027
http://dx.doi.org/10.1097/MD.0000000000025659
_version_ 1783695532629164032
author Raimbeau, Alizée
Pistorius, Marc-Antoine
Goueffic, Yann
Connault, Jérôme
Plissonneau-Duquene, Pierre
Maurel, Blandine
Reignier, Jean
Asehnoune, Karim
Artifoni, Mathieu
Didier, Quentin
Gautier, Giovanni
Trochu, Jean-Nöel
Rozec, Bertrand
N’Gohou, Chan
Durant, Cécile
Pottier, Pierre
Denis Le Sève, Julien
Brebion, Nicolas
Agard, Christian
Espitia, Olivier
author_facet Raimbeau, Alizée
Pistorius, Marc-Antoine
Goueffic, Yann
Connault, Jérôme
Plissonneau-Duquene, Pierre
Maurel, Blandine
Reignier, Jean
Asehnoune, Karim
Artifoni, Mathieu
Didier, Quentin
Gautier, Giovanni
Trochu, Jean-Nöel
Rozec, Bertrand
N’Gohou, Chan
Durant, Cécile
Pottier, Pierre
Denis Le Sève, Julien
Brebion, Nicolas
Agard, Christian
Espitia, Olivier
author_sort Raimbeau, Alizée
collection PubMed
description Upper extremity digital ischaemia (UEDI) is a rare heterogeneous condition whose frequency is 40 times less than that of toe ischaemia. Using a large cohort, the aim of this study was to evaluate aetiologies, prognosis and midterm clinical outcomes of UEDI. All patients with UEDI with or without cutaneous necrosis in a university hospital setting between January 2000 to December 2016 were included. Aetiologies, recurrence of UEDI, digital amputation and survival were analyzed retrospectively. Three hundred twenty three patients were included. UEDI due to cardio-embolic disease (DICE) was the highest occurring aetiology with 59 patients (18.3%), followed by DI due to Systemic Sclerosis (SSc) (16.1%), idiopathic causes (11.7%), Thromboangiitis obliterans (TAO) (9.3%), iatrogenic causes (9.3%), and cancer (6.2%). DICE patients tended to be older and featured more cases with arterial hypertension whereas TAO patients smoked more tobacco and cannabis. During follow-up, recurrences were significantly more frequent in SSc than in all other tested groups (P < .0001 vs idiopathic and DICE, P = .003 vs TAO) and among TAO patients when compared to DICE patients (P = .005). The cumulated rate of digital amputation was higher in the SSc group (n = 18) (P = .02) and the TAO group (n = 7) (P = .03) than in DICE (n = 2). This retrospective study suggests that main aetiologies of UEDI are DICE, SSc and idiopathic. This study highlights higher frequency of iatrogenic UEDI than previous studies. UEDI associated with SSc has a poor local prognosis (amputations and recurrences) and DICE a poor survival. UEDI with SSc and TAO are frequently recurrent.
format Online
Article
Text
id pubmed-8136985
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-81369852021-05-25 Digital ischaemia aetiologies and mid-term follow-up: A cohort study of 323 patients Raimbeau, Alizée Pistorius, Marc-Antoine Goueffic, Yann Connault, Jérôme Plissonneau-Duquene, Pierre Maurel, Blandine Reignier, Jean Asehnoune, Karim Artifoni, Mathieu Didier, Quentin Gautier, Giovanni Trochu, Jean-Nöel Rozec, Bertrand N’Gohou, Chan Durant, Cécile Pottier, Pierre Denis Le Sève, Julien Brebion, Nicolas Agard, Christian Espitia, Olivier Medicine (Baltimore) 3400 Upper extremity digital ischaemia (UEDI) is a rare heterogeneous condition whose frequency is 40 times less than that of toe ischaemia. Using a large cohort, the aim of this study was to evaluate aetiologies, prognosis and midterm clinical outcomes of UEDI. All patients with UEDI with or without cutaneous necrosis in a university hospital setting between January 2000 to December 2016 were included. Aetiologies, recurrence of UEDI, digital amputation and survival were analyzed retrospectively. Three hundred twenty three patients were included. UEDI due to cardio-embolic disease (DICE) was the highest occurring aetiology with 59 patients (18.3%), followed by DI due to Systemic Sclerosis (SSc) (16.1%), idiopathic causes (11.7%), Thromboangiitis obliterans (TAO) (9.3%), iatrogenic causes (9.3%), and cancer (6.2%). DICE patients tended to be older and featured more cases with arterial hypertension whereas TAO patients smoked more tobacco and cannabis. During follow-up, recurrences were significantly more frequent in SSc than in all other tested groups (P < .0001 vs idiopathic and DICE, P = .003 vs TAO) and among TAO patients when compared to DICE patients (P = .005). The cumulated rate of digital amputation was higher in the SSc group (n = 18) (P = .02) and the TAO group (n = 7) (P = .03) than in DICE (n = 2). This retrospective study suggests that main aetiologies of UEDI are DICE, SSc and idiopathic. This study highlights higher frequency of iatrogenic UEDI than previous studies. UEDI associated with SSc has a poor local prognosis (amputations and recurrences) and DICE a poor survival. UEDI with SSc and TAO are frequently recurrent. Lippincott Williams & Wilkins 2021-05-21 /pmc/articles/PMC8136985/ /pubmed/34011027 http://dx.doi.org/10.1097/MD.0000000000025659 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 3400
Raimbeau, Alizée
Pistorius, Marc-Antoine
Goueffic, Yann
Connault, Jérôme
Plissonneau-Duquene, Pierre
Maurel, Blandine
Reignier, Jean
Asehnoune, Karim
Artifoni, Mathieu
Didier, Quentin
Gautier, Giovanni
Trochu, Jean-Nöel
Rozec, Bertrand
N’Gohou, Chan
Durant, Cécile
Pottier, Pierre
Denis Le Sève, Julien
Brebion, Nicolas
Agard, Christian
Espitia, Olivier
Digital ischaemia aetiologies and mid-term follow-up: A cohort study of 323 patients
title Digital ischaemia aetiologies and mid-term follow-up: A cohort study of 323 patients
title_full Digital ischaemia aetiologies and mid-term follow-up: A cohort study of 323 patients
title_fullStr Digital ischaemia aetiologies and mid-term follow-up: A cohort study of 323 patients
title_full_unstemmed Digital ischaemia aetiologies and mid-term follow-up: A cohort study of 323 patients
title_short Digital ischaemia aetiologies and mid-term follow-up: A cohort study of 323 patients
title_sort digital ischaemia aetiologies and mid-term follow-up: a cohort study of 323 patients
topic 3400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136985/
https://www.ncbi.nlm.nih.gov/pubmed/34011027
http://dx.doi.org/10.1097/MD.0000000000025659
work_keys_str_mv AT raimbeaualizee digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT pistoriusmarcantoine digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT gouefficyann digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT connaultjerome digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT plissonneauduquenepierre digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT maurelblandine digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT reignierjean digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT asehnounekarim digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT artifonimathieu digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT didierquentin digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT gautiergiovanni digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT trochujeannoel digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT rozecbertrand digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT ngohouchan digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT durantcecile digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT pottierpierre digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT denislesevejulien digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT brebionnicolas digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT agardchristian digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients
AT espitiaolivier digitalischaemiaaetiologiesandmidtermfollowupacohortstudyof323patients